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476a Tuesday, March 3, 2009Administration of 10 and 30 mg/kg SKA-31 lowered mean arterial blood pres-
sure by 4 and 6 mmHg in normotensive mice and by 12 mmHg in angiotensin-
II-induced hypertension. These effects were absent in KCa3.1-deficient mice.
In conclusion, with SKA-31 we have designed a new pharmacological tool
to define the functional role of KCa2/3 channel activation in vivo. The blood
pressure lowering effect of SKA-31 suggests KCa3.1 channel activation as
a new therapeutic principle for the treatment of hypertension.
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Airway epithelial cells are the site of Cl- secretion through the cystic fibrosis
transmembrane regulator (CFTR). Cystic fibrosis (CF) is a fatal genetic disease
caused bymutations in CFTR. Themost frequent mutation consists of a deletion
of the phenylalanine at position 508 (DF508-CFTR) that impairs protein mat-
uration and alters channel gating. In the last years, several small molecules
were identified by high throughput screening that could restore DF508-CFTR
function. Compounds addressing DF508-CFTR gating defects are referred to
as potentiators and have been documented to increase the activity of DF508-
CFTR to a level similar to wild-type CFTR. The basolateral Kþ channel
KCa3.1 has been documented to play a prominent role in establishing a suitable
driving force for CFTR-mediated Cl- secretion in airway epithelial cells. Thus,
in a global approach of transepithelial transport, the research for physiologi-
cally relevant DF508-CFTR potentiators should also consider their effects on
the KCa3.1 channel. A characterization of the effect of different DF508-
CFTR potentiators on the KCa3.1 channel was undertaken using inside-out
patch clamp measurements on cDNA injected xenopus oocytes and on trans-
formed HEK-293 cells that express the KCa3.1 channel. In this work we pres-
ent preliminary results on the effects of different DF508-CFTR potentiators on
KCa3.1. Our inside-out patch-clamp measurements show that VRT-532 has
a state independent inhibitory effect on KCa3.1, but very little action on the
V282G mutant of KCa3.1, which is constitutively active. In contrast, CBIQ
succeded to activate KCa3.1, through a mechanism likely to involve an action
on the channel gate. These effects were observed at concentrations known to
activate DF508-CFTR. Supported by CCFF.
2455-Pos Board B425
Mechanism of Benzofuroindole-induced Potentiation of BKCa channel
Byoung-Cheol Lee1, Hyun-Ho Lim2, Yong-Chul Kim1, Chul-Seung Park1.
1Gwangju institute of science and technology, Gwangju, Republic of Korea,
2Department of Biochemistry, Howard Hughes Medical Institute, Brandeis
University, Waltham, MA, USA.
In our previous studies, we reported that the activity of the large-conductance
calcium-activated potassium channels (BKCa channel) could be strongly poten-
tiated by certain derivatives of benzofuroindole scaffold (Gormemis et al., 2005;
Ha et al., 2006). Here, we characterized the mechanism of action of these com-
pounds. Benzofuroindoles potentiated the channel by shifting its conductance-
voltage relations toward themore negative directionwithout affecting its voltage
sensitivity. This drug was proven to act on the alpha-subunit of the channel
(Slo1) from the extracellular side. The dose-response curve of the drug could
be well fitted with the Hill coefficient close to 1. While the apparent affinity of
the drugswas not affect by tetraethyl ammonium, a channel-blocking quaternary
ammonium, the co-treatment of charybdotoxin significantly decreased the po-
tency of the compounds, suggesting the potential competition between the
drug and the peptide blocker. Guided by these results, we performed the muta-
genesis studies on the outer vestibule of the BKCa channel in order to localize
the drug binding site. Among one deletion and 19 alanine substitutions, fourmu-
tant channels showed significantly smaller shifts in their conductance-voltage
curves by the drug treatment compared to the wild-type. Since these mutations
were clustered at the ‘turret’ region of the channel, benzofuroindole derivatives
may stabilize the open conformation of BKCa channel by binding to this area.
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Kþ movement across mitochondrial membranes is involved in volume regula-
tion and may play a role in cardioprotection. The Ca2þ-dependent Kþ (KCa)
channel has been proposed as a contributor tomitochondrial Kþ uniport activity,
but its functional role is not well understood. To investigate the impact of KCa
channels on mitochondrial energetics, we measured Kþ fluxes in parallel with
DJm and light scattering in isolated mitochondria from guinea pig hearts. We
first analyzed the role of different anions on Kþ fluxes. Mitochondria loadedwith the Kþ-sensitive fluorescent probe PBFI were incubated with 5mM gluta-
mate-Naþ/malate-Naþ in isotonic sucrose medium and subjected to pulses con-
taining different concentrations of KCl, KAc or KH2PO4. K
þ fluxes saturated at
z10mM regardless of the anion, attaining maximal rates (nmol Kþ/min/mg) of
172517 (KCl), 8452.4 (KAc), and 7453.8 (KH2PO4), with similar K0.5 in all
three cases. We then analyzed the effect of NS11021, a novel activator of KCa
channels, on the maximal Kþ uptake rate. In the presence of KH2PO4 or KAc,
20-50nM of NS11021 increased mitochondrial volume and Kþ flux by ~2.5-
fold whereas KCl increased Kþ uptake by 30% with little change in volume.
DJm was minimally affected in this concentration range. The NS11021 effect
was blocked by 200nM charybdotoxin, a KCa channel blocker. At 50nM
NS11021, the respiratory control ratio of the mitochondria increased 2.5-fold
in the presence of KH2PO4, but not KCl, indicating that a regulatory volume in-
crease is required to improve oxidative phosphorylation. At higher concentra-
tions of the compound (R1mM) substantial effects on DJm and state 4 respira-
tion were observed, which were not inhibited by Chtx. The findings indicate that
activation of Kþ fluxes through KCa channels, coupled with swelling without
loss of DJm, improves mitochondrial energetic performance.Cyclic Nucelotide-gated Channels
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MlotiK1 is a cyclic nucleotide-dependent ion channel which contains an intra-
cellular C-terminal cyclic nucleotide binding domain (CNB domain). We have
used X-ray crystallography to determine several different structures of the Mlo-
tiK1 CNB domain structures in the bound and unbound state. In combination,
the five MlotiK1 CNB domain structures provide a unique opportunity for an-
alyzing, within a single protein, the structural differences between the apo and
bound states and the structural variability within each state. With this analysis
as a guide, we have probed the nucleotide selectivity and importance of specific
residue side chains in ligand binding and channel activation. These data help to
identify ligand-protein interactions that are important for ligand-dependence in
this channel and more globally in the class of nucleotide-dependent proteins.
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Activity of cyclic nucleotide-gated (CNG)cation channels underlies signal trans-
duction in vertebrate visual receptors. These channels must be primarily acti-
vated by the binding of cGMP so that the activity of these highly specialized re-
ceptor channels be controlled by ligands in a finely graded manner required for
transducing sensory stimuli of varying intensity. Significant voltage sensitivity
of the channels would generate voltage-driven positive feedback and thus reduce
the signal-transduction sensitivity. Indeed, the CNGA1 channel is onlymodestly
voltage sensitive in low cGMP concentrations, and the voltage sensitivity van-
ishes with increasing cGMP concentration.We have found that loosening the at-
tachment of the selectivity filter to the surrounding ‘‘pore shell’’ dramatically in-
creases the channel’s voltage sensitivity, which is independent of the positively
charged residues in S4. Thus, proper attachment of the selectivity filter is essen-
tial to avoid significant, adverse voltage sensitivity in these channels.
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Hyperpolarization-activated Cyclic Nucleotide-modulated (HCN) channels un-
derlie the funny current or the hyperpolarization-activated current (If or Ih),
which is important in regulating excitability in the neurons of the central nervous
system and in the conduction tissue of the heart. There are four mammalian iso-
forms of HCN channels (HCN1-4), each exhibiting different kinetics, voltage
dependence, andamounts of inward, time-dependent current (If).Lidocaine, a lo-
cal anesthetic and antiarrhythmic drug, has been shown to inhibitHCN-mediated
currents in the rabbit sinoatrial (SA) node, which expresses various HCN iso-
forms. Previously, we showed that lidocaine, at concentrations ranging from
20 to 200 mM, inhibits mouse HCN1 channels, but the rate and extent of both
